At what enterprise value was PÉTERS SURGICAL acquired in 2013?

During the acquisition of PÉTERS SURGICAL by EURAZEO in 2013, the transaction's Enterprise Value is estimated to be in the range of 20M - 50M EUR.

What was the EV/EBITDA of PÉTERS SURGICAL when it was acquired by EURAZEO?

The estimated EV/EBITDA multiple for PÉTERS SURGICAL is in the range of 5x - 12x.

When was PÉTERS SURGICAL acquired by EURAZEO?

PÉTERS SURGICAL was acquired by EURAZEO in 2013.

What was the revenue of PÉTERS SURGICAL at the time of the deal?

The revenue of PÉTERS SURGICAL at the time of the deal is estimated to be in the range of 25M - 50M EUR.

What was the EBITDA of PÉTERS SURGICAL during the acquisition?

PÉTERS SURGICAL's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the PÉTERS SURGICAL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the PÉTERS SURGICAL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.fusacq.com/buzz/eurazeo-pme-acquiert-peters-surgical-n4-mondial-de-la-suture-chirurgicale-a55257_fr_

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaPÉTERS SURGICAL

06/2013

PÉTERS SURGICAL acquired by EURAZEO

FRANCE Life Sciences / Medical Devices / Medical Consumables EV 20M - 50M EUR

Context

The acquisition of Péters Surgical by Eurazeo PME is a strategic move that reflects the investment firm's commitment to supporting the growth and development of medium-sized enterprises in the healthcare sector. With its strong track record of investing in medical device companies, Eurazeo PME will provide Péters Surgical with the financial and strategic support it needs to continue expanding its product offerings and increasing its international presence. The deal is expected to be completed by the end of July 2013, with Eurazeo PME acquiring approximately 90% of Péters Surgical's capital. The company's management team, including President and CEO Jean-Marc Chalot, will retain a significant stake in the business and will continue to play a key role in driving its growth and development. The acquisition is expected to provide Péters Surgical with the resources it needs to pursue its strategic objectives, including expanding its product lines and increasing its presence in emerging markets. With its strong reputation for quality and innovation, Péters Surgical is well-positioned to become a leading player in the global medical device industry, and Eurazeo PME's support will be instrumental in helping the company achieve its full potential.

PÉTERS SURGICAL, which reported an EBITDA margin of in 2012, is valued in this transaction at an EV/EBITDA multiple of , a level than the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Péters Surgical is a French company that designs, manufactures, and distributes a range of single-use medical devices for operating rooms. The company's primary product lines include surgical sutures, wall reinforcements, and drains. Founded in 1926 and based in Bobigny, Péters Surgical has established a strong presence in the French market and exports its products to over 75 countries worldwide. The company's business model is centered on building close relationships with its clients, including public hospitals and private clinics, and it has developed a network of agents and distributors to support its international sales efforts. With a workforce of approximately 350 employees, Péters Surgical has demonstrated significant growth in recent years, with revenue increasing from 24 million euros in 2009 to 37 million euros in 2012. The company's products are designed to meet the specific needs of surgical professionals, and its commitment to quality and innovation has enabled it to establish a strong reputation in the medical device industry.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2012

2011

Other operations with PÉTERS SURGICAL

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
03/2024	ADVANCED MEDICAL SOLUTIONS GROUP	PÉTERS SURGICAL	FRANCE	Medical Consumables

REFERENCES

Valuation range: EV 20M - 50M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PÉTERS SURGICAL by EURAZEO are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: péters surgical

Acquirer: eurazeo